Stay updated on AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.

Latest updates to the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record history shows the addition of Revision: v3.3.2 and the deletion of Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedA new revision entry v3.3.1 was added to the record history and the previous revision v3.2.0 was removed.SummaryDifference0.1%

- Check29 days agoChange Detected- The government funding/operating status notice at the top of the page was removed.SummaryDifference0.8%

- Check43 days agoChange DetectedA new version entry dated 2024-05-23 was added to the Record History, reflecting updates to the study's status and recruitment details.SummaryDifference0.1%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.